Recall Record

Princeton, NJ, United States

Abbott Point Of Care Inc. recalls

9 recalls recorded since 2018, most recently on 1 April 2026. 3 are listed as ongoing. Status and classification are as published by the FDA.

Recalls9
Ongoing (FDA)3
Terminated or completed6
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
1 April 2026
Reason
Approximately 7.6% of cartridges from specific i-STAT EG7+ (list number 03P76-25), i-STAT EG6+ (list number 03P77-25) and i-STAT G3+ (list number 03P78-26) cartridge lots in the U.S. marketplace may report higher than expected PCO2 and lower than expected pH results due to a manufacturing issue. A falsely high pCO2 together with a falsely low pH makes the blood gas appear as if the patient is in severe respiratory acidosis. If the clinician believes the values are real, it may trigger unnecessary or even harmful interventions such as unnecessary ventilator changes, unnecessary medications, potential harm from overcorrection, or delays in identifying true problems.
Distribution
Worldwide distribution - US Nationwide and the countries of Canada, AUSTRIA, BANGLADESH, BELGIUM, FINLAND, FRANCE, GERMANY, IRELAND, ITALY, LUXEMBOURG, MAURITIUS, NETHERLANDS, NORWAY, POLAND, PORTUGAL, SPAIN, SWEDEN, SWITZERLAND, UNITED KINGDOM.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2001-2026, Z-1999-2026, Z-2000-2026

Ongoing Class II Medical devices

Recall started
21 August 2025
Reason
Lack of a 510(k) premarket clearance for the i-STAT CG8+, EG7+ and EG6+ cartridges to reflect updated sample type for potassium and ionized calcium and measurement ranges for pH and PO2.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2585-2025, Z-2583-2025, Z-2584-2025

Ongoing Class II Medical devices

Recall started
21 August 2025
Reason
Lack of a 510(k) premarket clearance for the i-STAT CG4+ cartridge to reflect updated sample type for lactate and measurement ranges for pH and PO2.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-2582-2025

Terminated Class II Medical devices

Recall started
22 December 2020
Terminated
1 September 2023
Reason
Ionized calcium test on some i-STAT CG8+ and EG7+ cartridges may exhibit higher than expected reported results when stored at room temperature (18 to 30C) for periods of time in excess of 3 days for lot numbers *20100 to *20339 and 7 days for lot numbers *20340 and above Where * = lot letter A, K, L, M, N, W or Y.
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0880-2021, Z-0881-2021

Terminated Class II Medical devices

Recall started
15 January 2020
Terminated
2 March 2021
Reason
The I-STAT BLUE CHEM8+ and CG4+ cartridges are not FDA cleared and do not have CLIA waived status. CLIA recognizes two types of laboratory tests: waived and non-waived. Different CLIA standards apply to waived and non-waived tests as well as the facilities that perform these types of tests. The i-STAT CHEM8+ cartridge contains nine measured assays (sodium, potassium, chloride, blood urea nitrogen (BUN), ionized calcium, TCO2, glucose, creatinine and hematocrit) and is categorized as a CLIA waived test for venous whole blood samples, meaning this cartridge could be used in a facility with a CLIA Certificate of Waiver as a waived test.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1263-2020, Z-1262-2020

Terminated Class II Medical devices

Recall started
14 January 2020
Terminated
12 April 2021
Reason
Marketed without a 510(k). Abbott Point of Care has determined that it does not have sufficient clinical evidence to fully characterize the performance of the blue i-STAT G3+ cartridges and therefore will no longer distribute the i-STAT G3+ (blue) cartridge in the United States as of May 1, 2020.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1265-2020

Terminated Class II Medical devices

Recall started
16 October 2019
Terminated
4 May 2020
Reason
i-STAT¿ cTnI blue cartridges may generate a higher than expected number of quality check codes. The observed rate of quality check codes could be in the 3 to 5% range.
Distribution
US: AK AL AZ CA CT DC FL GA HI IL IN KS KY MD MI MS NC NE NH NM NV NY OH OK OR PA SC SD TN TX VA WA WV WY
Initiated
Voluntary: Firm initiated
Recall number
Z-0761-2020

Terminated Class II Medical devices

Recall started
13 September 2018
Terminated
4 April 2019
Reason
Inaccurate potassium results may be generated. When testing with control fluid and/or patient samples with low or reference range potassium concentration, elevated potassium results may be generated. When testing with samples with a high concentration of potassium, decreased potassium results may be generated
Distribution
WI
Initiated
Voluntary: Firm initiated
Recall number
Z-0615-2019

Terminated Class II Medical devices

Recall started
12 September 2017
Terminated
23 August 2018
Reason
Issues resulting from upgrade to software version 2.8: (1) Location, operator, stored patient lists will not update, and (2) Customized Reference Ranges, Action Ranges, and Custom Reportable Ranges are reset to factory default values. No erroneous results are generated as a result of this issue.
Distribution
Distributed in 48 States: AK, AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY, the District of Columbia, Australia, Italy, Sweden, and Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-0926-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.